• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

糖原贮积病 I 型患儿(年龄<5 岁)的营养管理:调查结果。

Nutrition Management in Children Less than 5 Years of Age with Glycogen Storage Disease Type I: Survey Results.

机构信息

Division of Metabolics, Children's Hospital of Orange County, Orange, CA 92868, USA.

Division of Medical Genetics, Department of Pediatrics, Duke University Medical Center, Durham, NC 27710, USA.

出版信息

Nutrients. 2024 Sep 25;16(19):3244. doi: 10.3390/nu16193244.

DOI:10.3390/nu16193244
PMID:39408211
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11478432/
Abstract

Nutrition management for GSD Type I (GSDI; OMIM #232200, 232220) is complex, with the goal being to maintain euglycemia while minimizing metabolic derangements. Management guidelines were published in 2002 and 2014. However, there is limited information on the nuances of nutrition management and the unique feeding challenges of children. A REDCap survey focusing on staffing and current practices in the nutrition management of children with GSD I who were <5 years of age was sent to the metabolic dietitian's listserv and GMDI membership in 8/2023. There were 21 North American respondents. In 17/21 clinics (81%), Prosobee was the primary choice for infant formula. Dietitians used different methods to determine hourly glucose needs. Fasting recommendations ranged from 1 to 3 h, and the use of nighttime continuous feeding was common. Cornstarch was started between 6 and 12 months of age. Most clinics did not use Glycosade for children <5 years of age. Oral motor dysfunction, gagging, and lack of interest in food were common. Continuous glucose monitoring (CGM) devices were recommended in 20 clinics (95%). Most clinics followed patients on an outpatient basis. All clinics provided a hypoglycemia management plan; however, there was wide variability in practice. This survey highlights the variability in the care of individuals <5 years of age with GSD I. Updated guidelines are needed to help address the unique nutrition challenges in this age group.

摘要

I 型糖原贮积症(GSDI;OMIM #232200,232220)的营养管理较为复杂,目标是在将代谢紊乱最小化的同时维持血糖正常。管理指南已于 2002 年和 2014 年发布。然而,关于营养管理的细节以及儿童特殊喂养挑战的信息有限。2023 年 8 月,我们向代谢营养师的列表服务和 GMDI 成员发送了一份针对 5 岁以下 I 型糖原贮积症患儿营养管理的人员配备和当前实践情况的 REDCap 调查。共有 21 名北美受访者。在 21 个诊所中的 17 个(81%),Prosobee 是婴儿配方奶的主要选择。营养师使用不同的方法来确定每小时的葡萄糖需求量。禁食建议的时间范围从 1 小时到 3 小时不等,夜间连续喂养较为常见。玉米淀粉从 6 到 12 个月开始使用。大多数诊所不使用 Glycosade 治疗 5 岁以下儿童。口腔运动功能障碍、呛咳和对食物缺乏兴趣较为常见。20 个诊所(95%)建议使用连续血糖监测(CGM)设备。大多数诊所对门诊患者进行随访。所有诊所都提供低血糖管理计划;然而,实践中存在很大差异。本调查强调了 5 岁以下 I 型糖原贮积症患者护理的差异性。需要更新指南来帮助解决该年龄段的特殊营养挑战。

相似文献

1
Nutrition Management in Children Less than 5 Years of Age with Glycogen Storage Disease Type I: Survey Results.糖原贮积病 I 型患儿(年龄<5 岁)的营养管理:调查结果。
Nutrients. 2024 Sep 25;16(19):3244. doi: 10.3390/nu16193244.
2
Glycogen Storage Disease Type IIIIII型糖原贮积病
3
Continuous glucose monitoring in children with glycogen storage disease type I.儿童糖原贮积病Ⅰ型的连续血糖监测。
Eur J Clin Nutr. 2014 Jan;68(1):101-5. doi: 10.1038/ejcn.2013.186. Epub 2013 Oct 23.
4
Nutrition therapy for hepatic glycogen storage diseases.肝糖原贮积病的营养治疗
J Am Diet Assoc. 1993 Dec;93(12):1423-30. doi: 10.1016/0002-8223(93)92246-t.
5
Development of minimally invasive C-glucose breath test to examine different exogenous carbohydrate sources in patients with glycogen storage disease type Ia.开发微创C-葡萄糖呼气试验以检测Ia型糖原贮积病患者的不同外源性碳水化合物来源。
Mol Genet Metab Rep. 2022 May 11;31:100880. doi: 10.1016/j.ymgmr.2022.100880. eCollection 2022 Jun.
6
Alternative nighttime nutrition regimens in glycogen storage disease type I: a controlled crossover study.糖原贮积病I型的替代夜间营养方案:一项对照交叉研究。
J Inherit Metab Dis. 2015 Nov;38(6):1093-8. doi: 10.1007/s10545-015-9864-2. Epub 2015 Jun 25.
7
Impact of hematopoietic stem cell transplantation in glycogen storage disease type Ib: A single-subject research design using C-glucose breath test.造血干细胞移植对Ⅰb型糖原贮积病的影响:一项采用¹³C-葡萄糖呼气试验的单病例研究设计
Mol Genet Metab Rep. 2023 Jan 3;34:100955. doi: 10.1016/j.ymgmr.2023.100955. eCollection 2023 Mar.
8
Cornstarch requirements of the adult glycogen storage disease Ia population: A retrospective review.成人糖原贮积病 Ia 人群的淀粉需求:回顾性研究。
J Inherit Metab Dis. 2020 Mar;43(2):269-278. doi: 10.1002/jimd.12160. Epub 2019 Sep 4.
9
Glycogen Storage Disease Type II型糖原贮积病
10
Effect of continuous glucose therapy begun in infancy on the long-term clinical course of patients with type I glycogen storage disease.婴儿期开始的持续葡萄糖治疗对I型糖原贮积病患者长期临床病程的影响。
J Pediatr Gastroenterol Nutr. 1999 Aug;29(2):136-43. doi: 10.1097/00005176-199908000-00008.

引用本文的文献

1
Feeding Difficulties in Children with Hepatic Glycogen Storage Diseases Identified by a Brazilian Portuguese Validated Screening Tool.使用巴西葡萄牙语验证的筛查工具识别肝糖原累积病患儿的喂养困难
Nutrients. 2025 May 23;17(11):1758. doi: 10.3390/nu17111758.

本文引用的文献

1
The Psychological Benefits of Breastfeeding: Fostering Maternal Well-Being and Child Development.母乳喂养的心理益处:促进母亲幸福感与儿童发展。
Cureus. 2023 Oct 9;15(10):e46730. doi: 10.7759/cureus.46730. eCollection 2023 Oct.
2
Endogenous Glucose Production in Patients With Glycogen Storage Disease Type Ia Estimated by Oral D-[6,6-2H2]-glucose.采用口服 D-[6,6-2H2]-葡萄糖估算Ⅰa 型糖原贮积症患者的内源性葡萄糖生成。
J Clin Endocrinol Metab. 2024 Jan 18;109(2):389-401. doi: 10.1210/clinem/dgad537.
3
Treating neutropenia and neutrophil dysfunction in glycogen storage disease type Ib with an SGLT2 inhibitor.用 SGLT2 抑制剂治疗糖原贮积病 Ib 型的中性粒细胞减少症和中性粒细胞功能障碍。
Blood. 2020 Aug 27;136(9):1033-1043. doi: 10.1182/blood.2019004465.
4
Breast Milk, a Source of Beneficial Microbes and Associated Benefits for Infant Health.母乳:有益微生物的来源及其对婴儿健康的益处。
Nutrients. 2020 Apr 9;12(4):1039. doi: 10.3390/nu12041039.
5
Components of human breast milk: from macronutrient to microbiome and microRNA.人乳的成分:从宏量营养素到微生物群和微小RNA
Clin Exp Pediatr. 2020 Aug;63(8):301-309. doi: 10.3345/cep.2020.00059. Epub 2020 Mar 23.
6
Dietary Management of the Glycogen Storage Diseases: Evolution of Treatment and Ongoing Controversies.糖原贮积病的饮食管理:治疗方法的演变及持续存在的争议。
Adv Nutr. 2020 Mar 1;11(2):439-446. doi: 10.1093/advances/nmz092.
7
Hepatic glycogen storage diseases are associated to microbial dysbiosis.肝糖原贮积病与微生物失调有关。
PLoS One. 2019 Apr 2;14(4):e0214582. doi: 10.1371/journal.pone.0214582. eCollection 2019.
8
Failure to eliminate a phosphorylated glucose analog leads to neutropenia in patients with G6PT and G6PC3 deficiency.未能消除磷酸化葡萄糖类似物会导致 G6PT 和 G6PC3 缺陷患者中性粒细胞减少。
Proc Natl Acad Sci U S A. 2019 Jan 22;116(4):1241-1250. doi: 10.1073/pnas.1816143116. Epub 2019 Jan 9.
9
Role of continuous glucose monitoring in the management of glycogen storage disorders.连续血糖监测在糖原贮积症管理中的作用。
J Inherit Metab Dis. 2018 Nov;41(6):917-927. doi: 10.1007/s10545-018-0200-5. Epub 2018 May 25.
10
Diagnosis and management of glycogen storage disease type I: a practice guideline of the American College of Medical Genetics and Genomics.I型糖原贮积病的诊断与管理:美国医学遗传学与基因组学学会实践指南
Genet Med. 2014 Nov;16(11):e1. doi: 10.1038/gim.2014.128.